Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
QNRX Quoin Pharmaceuticals
- 6.411
- -0.169-2.57%
Trading Apr 30 14:07 ET
3.77MMarket Cap-0.10P/E (TTM)
6.950High6.280Low29.65KVolume6.780Open6.580Pre Close195.89KTurnover5.43%Turnover RatioLossP/E (Static)588.17KShares54.95052wk High0.41P/B3.50MFloat Cap5.01052wk Low--Dividend TTM546.54KShs Float1417500.000Historical High--Div YieldTTM10.18%Amplitude5.010Historical Low6.606Avg Price1Lot Size
Quoin Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 7.27%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 26.90%-1.57M | 16.58%-1.75M |
| Net income from continuing operations | -3.18%-8.96M | -12.75%-2.31M | -21.97%-2.35M | 6.31%-1.97M | 10.59%-2.33M | 7.41%-8.69M | -2.44%-2.05M | 36.40%-1.93M | 21.03%-2.11M | -54.69%-2.6M |
| Depreciation and amortization | -3.57%100K | -2.63%25K | -3.88%25K | -3.89%25K | -3.89%25K | -0.32%103.71K | -1.30%25.67K | -0.00%26.01K | 0.00%26.01K | 0.00%26.01K |
| Change In working capital | -102.24%-2.14K | 84.87%-211.5K | -122.71%-102.05K | -201.83%-347.2K | -6.27%658.61K | 201.16%95.45K | -200.78%-1.4M | 273.37%449.35K | 30.47%340.97K | 90.87%702.67K |
| -Change in prepaid assets | -769.73%-278.09K | -49.32%-595.2K | 138.81%376.77K | -146.02%-75.79K | -86.29%16.13K | -66.37%41.52K | -0.83%-398.6K | -52.21%157.77K | 1,049.88%164.68K | -42.88%117.68K |
| -Change in payables and accrued expense | 411.75%275.96K | 138.41%383.7K | -264.21%-478.81K | -253.95%-271.41K | 9.83%642.48K | 124.76%53.92K | -1,341.21%-998.95K | 149.48%291.59K | -36.74%176.29K | 260.81%584.99K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 7.27%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 26.90%-1.57M | 16.58%-1.75M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 121.56%2.19M | 2.64M | 100.01%821 | 1,617.50%3.04M | -6,883.01%-3.49M |
| Net investment purchase and sale | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 122.11%2.19M | --2.64M | 100.01%821 | --3.04M | ---3.49M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -186.29%-1.89M | -220.21%-3.18M | 316,685.75%2.6M | 3.95%3.16M | -27.90%-4.47M | 121.56%2.19M | --2.64M | 100.01%821 | 1,617.50%3.04M | -6,883.01%-3.49M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -62.76%5.22M | 59.14%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Net other financing activities | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -63.57%5.22M | -35.05%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 110.24%10.97M | 3,343.14%5.92M | 45.49%-149.89K | -81.70%-136.28K | -7.25%5.33M | -62.76%5.22M | 59.14%-182.58K | -101.86%-275K | 50.00%-75K | 3,932.84%5.75M |
| Net cash flow | ||||||||||
| Beginning cash position | -16.06%2.4M | -1.48%3.12M | -40.22%2.85M | -45.62%1.83M | -16.06%2.4M | -61.77%2.86M | -39.74%3.16M | 77.06%4.76M | -35.02%3.37M | -61.77%2.86M |
| Current changes in cash | 366.01%1.22M | 166.46%506.59K | 117.02%271.62K | -27.08%1.01M | -211.04%-567.67K | 90.06%-459.43K | 68.10%-762.23K | -162.28%-1.6M | 155.46%1.39M | 122.29%511.23K |
| End cash Position | 50.90%3.62M | 50.90%3.62M | -1.48%3.12M | -40.22%2.85M | -45.62%1.83M | -16.06%2.4M | -16.06%2.4M | -39.74%3.16M | 77.06%4.76M | -35.02%3.37M |
| Free cash flow | 0.09%-7.86M | 30.62%-2.24M | -64.91%-2.18M | -27.62%-2.01M | 17.87%-1.43M | 9.92%-7.86M | -65.97%-3.22M | 42.38%-1.32M | 33.11%-1.57M | 18.52%-1.75M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now